Startseite Effect of tibolone therapy on lipids and coagulation indices
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Effect of tibolone therapy on lipids and coagulation indices

  • Rose Daher , Hadi Al-Amin , Mona Beaini und Ihab Usta
Veröffentlicht/Copyright: 21. September 2011
Veröffentlichen auch Sie bei De Gruyter Brill

Published Online: 2011-9-21
Published in Print: 2006-12-1

©2006 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Initiation and progression of atherosclerosis – enzymatic or oxidative modification of low-density lipoprotein?
  2. Blood transfusions in athletes. Old dogmas, new tricks
  3. Molecular detection of tyrosinase transcripts in peripheral blood from patients with malignant melanoma: correlation of PCR sensitivity threshold with clinical and pathologic disease characteristics
  4. Increase in and clearance of cell-free plasma DNA in hemodialysis quantified by real-time PCR
  5. Lipoprotein lipase gene polymorphism at the PvuII locus and serum lipid levels in Guangxi Hei Yi Zhuang and Han populations
  6. Interpretation of cardiac troponin T behaviour in size-exclusion chromatography
  7. Point-of-care C-reactive protein testing in febrile children in general practice
  8. Improvement in HPLC separation of porphyrin isomers and application to biochemical diagnosis of porphyrias
  9. Measurement of late-night salivary cortisol with an automated immunoassay system
  10. Combining markers of nephrotoxicity and hepatotoxicity for improved monitoring and detection of chronic alcohol abuse
  11. Stone or stricture as a cause of extrahepatic cholestasis – do liver function tests predict the diagnosis?
  12. Insulin resistance and enhanced protein glycation in men with prehypertension
  13. Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge
  14. Analytical performance and clinical utility of the INNOTEST® PHOSPHO-TAU(181P) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies
  15. Variations in assay protocol for the Dako cystatin C method may change patient results by 50% without changing the results for controls
  16. Approved IFCC recommendation on reporting results for blood glucose: International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division, Working Group on Selective Electrodes and Point-of-Care Testing (IFCC-SD-WG-SEPOCT)
  17. National survey on the pre-analytical variability in a representative cohort of Italian laboratories
  18. 10% CV concentration for the fourth generation Roche cardiac troponin T assay derived from Internal Quality Control data
  19. Biological variation of non-SI traceable biological quantities: example of proteins
  20. Effect of tibolone therapy on lipids and coagulation indices
  21. Acknowledgement
  22. Contents Volume 44, 2006
  23. Author Index
  24. Subject Index
Heruntergeladen am 20.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2006.269/html
Button zum nach oben scrollen